Zeng, Y., Li, A., Zhou, J., Wen, H., Zhang, K., Wu, Q., Wen, S. (2025). Cost-effectiveness of finotonlimab plus chemotherapy versus chemotherapy alone for recurrent or metastatic head and neck cancer in China. Scientific Reports. https://doi.org/10.1038/s41598-025-23864-5